Daniel Gruskin

Recombinant human acid α-glucosidase

Priya S. Kishnani, Deya Corzo, Marc Nicolino et al. · Neurology · 2006 · 772 citations · Full text

Life Sciences, Pharmacology, Pharmacotherapy +10

Early Treatment With Alglucosidase Alfa Prolongs Long-Term Survival of Infants With Pompe Disease

Priya S. Kishnani, Deya Corzo, Nancy D. Leslie et al. · Pediatric Research · 2009 · 339 citations · Full text

Pharmacy, Pediatrics, Pharmacotherapy +6

Efficacy of Sapropterin Dihydrochloride in Increasing Phenylalanine Tolerance in Children with Phenylketonuria: A Phase III, Randomized, Double-Blind, Placebo-Controlled Study

Friedrich K. Trefz, Barbara K. Burton, Nicola Longo et al. · The Journal of Pediatrics · 2009 · 192 citations

Pharmacy, Pediatrics, Pharmacotherapy +7

Social‐adaptive and psychological functioning of patients affected by Fabry disease

Dawn A. Laney, Daniel Gruskin, Paul M. Fernhoff et al. · Journal of Inherited Metabolic Disease · 2010 · 49 citations

Social Sciences, Psychiatry, Psychology +8

Reduction of Plasma Globotriaosylsphingosine Levels After Switching from Agalsidase Alfa to Agalsidase Beta as Enzyme Replacement Therapy for Fabry Disease

Özlem Göker-Alpan, Michael J. Gambello, Gustavo Maegawa et al. · JIMD Reports · 2015 · 30 citations · Full text

Life Sciences, Biochemistry, Pharmacotherapy +13